Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (≥60 years) and younger (18-59 years) adults.
Andermann E, Rosenfeld W, Penovich P, Rogin J, Cendes F, Carreño M, Ramsay RE, Ben-Menachem E, Gama H, Rocha F, Soares-da-Silva P, Tosiello R, Blum D, Grinnell T.
Andermann E, et al. Among authors: tosiello r.
Epilepsy Res. 2021 Jan;169:106478. doi: 10.1016/j.eplepsyres.2020.106478. Epub 2020 Oct 10.
Epilepsy Res. 2021.
PMID: 33338829
Free article.